Detection of β-amyloid positivity in Alzheimer’s Disease Neuroimaging Initiative participants with demographics, cognition, MRI and plasma biomarkers

In vivo gold standard for the ante-mortem assessment of brain β-amyloid pathology is currently β-amyloid positron emission tomography or cerebrospinal fluid measures of β-amyloid(42) or the β-amyloid(42)/β-amyloid(40) ratio. The widespread acceptance of a biomarker classification scheme for the Alzh...

Descripción completa

Detalles Bibliográficos
Autores principales: Tosun, Duygu, Veitch, Dallas, Aisen, Paul, Jack, Clifford R, Jagust, William J, Petersen, Ronald C, Saykin, Andrew J, Bollinger, James, Ovod, Vitaliy, Mawuenyega, Kwasi G, Bateman, Randall J, Shaw, Leslie M, Trojanowski, John Q, Blennow, Kaj, Zetterberg, Henrik, Weiner, Michael W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023542/
https://www.ncbi.nlm.nih.gov/pubmed/33842885
http://dx.doi.org/10.1093/braincomms/fcab008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023542/
https://www.ncbi.nlm.nih.gov/pubmed/33842885
http://dx.doi.org/10.1093/braincomms/fcab008

Ejemplares similares